- Home
- ACFN vs PYPD Comparison
ACFN vs PYPD Comparison
Compare ACFN & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- PYPD
- Stock Information
- Founded
- ACFN 1986
- PYPD 2008
- Country
- ACFN United States
- PYPD Israel
- Employees
- ACFN N/A
- PYPD N/A
- Industry
- ACFN Military/Government/Technical
- PYPD Medical/Dental Instruments
- Sector
- ACFN Consumer Discretionary
- PYPD Health Care
- Exchange
- ACFN Nasdaq
- PYPD Nasdaq
- Market Cap
- ACFN 63.5M
- PYPD 54.7M
- IPO Year
- ACFN N/A
- PYPD 2020
- Fundamental
- Price
- ACFN $25.11
- PYPD $3.71
- Analyst Decision
- ACFN
- PYPD Strong Buy
- Analyst Count
- ACFN 0
- PYPD 5
- Target Price
- ACFN N/A
- PYPD $12.00
- AVG Volume (30 Days)
- ACFN 15.4K
- PYPD 87.3K
- Earning Date
- ACFN 11-10-2025
- PYPD 11-12-2025
- Dividend Yield
- ACFN N/A
- PYPD N/A
- EPS Growth
- ACFN 1520.82
- PYPD N/A
- EPS
- ACFN 2.84
- PYPD N/A
- Revenue
- ACFN $13,202,000.00
- PYPD N/A
- Revenue This Year
- ACFN N/A
- PYPD N/A
- Revenue Next Year
- ACFN N/A
- PYPD N/A
- P/E Ratio
- ACFN $8.82
- PYPD N/A
- Revenue Growth
- ACFN 50.98
- PYPD N/A
- 52 Week Low
- ACFN $17.22
- PYPD $2.30
- 52 Week High
- ACFN $33.00
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- ACFN 45.65
- PYPD 65.39
- Support Level
- ACFN $23.00
- PYPD $3.10
- Resistance Level
- ACFN $26.47
- PYPD $3.77
- Average True Range (ATR)
- ACFN 1.74
- PYPD 0.17
- MACD
- ACFN -0.04
- PYPD 0.05
- Stochastic Oscillator
- ACFN 46.89
- PYPD 91.55
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.